[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394 − 424. http://dx.doi.org/10.3322/caac.21492CrossRef
[2] Clifford GM, Polesel J, Rickenbach M, Maso LD, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97(6): 425 − 32. https://academic.oup.com/jnci/article/97/6/425/2544168.https://academic.oup.com/jnci/article/97/6/425/2544168
[3] World Health Organization. Comprehensive cervical cancer control: a guide to essential practice, 2nd ed. World Health Organization. 2014. https://apps.who.int/iris/bitstream/handle/10665/144785/9789241548953_eng.pdf?sequence=1&isAllowed=y. [2020-04-27].https://apps.who.int/iris/bitstream/handle/10665/144785/9789241548953_eng.pdf?sequence=1&isAllowed=y
[4] Wang LY, Qin QQ, Ding ZW, Cai C, Guo W, Li DM, et al. Current situation of AIDS epidemic in China. Chin J AIDS STD 2017;23(4):330 − 3. http://dx.doi.org/10.13419/j.cnki.aids.2017.04.16 (In Chinese). CrossRef
[5] Luo XM, Song L, Wu JL, Liu Y, Di JL, Song B, et al. Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China. Chin J Prev Med 2016;50(4): 346 − 50. http://www.pubhealth.org.cn/doc/file/2016/4/0253-9624-50-04-012s.pdf. (In Chinese). http://www.pubhealth.org.cn/doc/file/2016/4/0253-9624-50-04-012s.pdf
[6] Shi JF, Belinson JL, Zhao FH, Pretorius RG, Li J, Ma JF, et al. Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China. Am J Epidemiol 2009;170(6):708 − 16. http://dx.doi.org/10.1093/aje/kwp188CrossRef
[7] Zhang XM, Zhang CY, Chen F, Li Y, Wang JL. Bayesian estimation of incidences of cervical carcinoma and cervical precancerous lesion in women aged 20 to 65 years in a given province. Chin Fam Plann 2013;21(12):796 − 9. http://www.cnki.com.cn/Article/CJFDTotal-JHSY201312001.htm. (In Chinese). http://www.cnki.com.cn/Article/CJFDTotal-JHSY201312001.htm
[8] Bao HL, Zhang L, Wang LM, Zhang M, Zhao ZP, Fang LW, et al. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med 2018;7(5):2089 − 100. http://dx.doi.org/10.1002/cam4.1321CrossRef
[9] Alliance for Cervical Cancer Prevention (ACCP). Planning and implementing cervical cancer prevention and control programs: a manual for managers. Seattle: ACCP; 2004. http://origin.searo.who.int/nepal/mediacentre/2004_planning_and_implementing_cervical_cancer_prevention_n_control_programs.pdf. [2020-04-27]http://origin.searo.who.int/nepal/mediacentre/2004_planning_and_implementing_cervical_cancer_prevention_n_control_programs.pdf
[10] Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 2012;131(12):2929 − 38. http://dx.doi.org/10.1002/ijc.27571CrossRef
[11] Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97(14):1072 − 9. http://dx.doi.org/10.1093/jnci/dji187CrossRef
[12] Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Recommend Rep 2014;63(RR05):1-30. https://www.cdc.gov/Mmwr/preview/mmwrhtml/rr6305a1.htm.https://www.cdc.gov/Mmwr/preview/mmwrhtml/rr6305a1.htm
[13] Zhang HY, Zhan JQ, Cao YG, Zhang WJ. Behavioral risk factors and cervical cancer in Chinese women: a meta-analysis. Chin J Cancer Prev Treat 2011;18(3):165 − 9. http://dx.doi.org/10.16073/j.cnki.cjcpt.2011.03.006 (In Chinese). CrossRef
[14] Clifford GM, Franceschi S, Keiser O, Schöni-Affolter F, Lise M, Dehler S, et al. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: a nested case-control study in the Swiss HIV cohort study. Int J Cancer 2016;138(7):1732 − 40. http://dx.doi.org/10.1002/ijc.29913CrossRef